<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNK7 Gene</th>
</tr>
<tr>
<td class="label">HGNC symbol</td>
<td>KCNK7</td>
</tr>
<tr>
<td class="label">Full name</td>
<td>Potassium two pore domain channel subfamily K member 7</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td>10091</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>ENSG00000184058</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>O43167</td>
</tr>
<tr>
<td class="label">Cytogenetic location</td>
<td>11q13.1</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
KCNK7 encodes potassium two-pore-domain channel subfamily K member 7 (K2P7), a member of the leak/background potassium channel superfamily that helps set resting membrane potential and excitability thresholds in [neurons](/entities/neurons).[@goldstein2005][@enyedi2010] Although KCNK7 is less experimentally resolved than channels such as KCNK2 (TREK1) or KCNK3 (TASK1), its predicted architecture and expression profile place it within core ion-homeostasis pathways relevant to neuronal vulnerability in neurodegeneration.[@goldstein2005][@feliciangeli2015]
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNK7 Gene</th>
</tr>
<tr>
<td class="label">HGNC symbol</td>
<td>KCNK7</td>
</tr>
<tr>
<td class="label">Full name</td>
<td>Potassium two pore domain channel subfamily K member 7</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td>10091</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td>ENSG00000184058</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>O43167</td>
</tr>
<tr>
<td class="label">Cytogenetic location</td>
<td>11q13.1</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
KCNK7 encodes potassium two-pore-domain channel subfamily K member 7 (K2P7), a member of the leak/background potassium channel superfamily that helps set resting membrane potential and excitability thresholds in [neurons](/entities/neurons).[@goldstein2005][@enyedi2010] Although KCNK7 is less experimentally resolved than channels such as KCNK2 (TREK1) or KCNK3 (TASK1), its predicted architecture and expression profile place it within core ion-homeostasis pathways relevant to neuronal vulnerability in neurodegeneration.[@goldstein2005][@feliciangeli2015]
The biological rationale for tracking KCNK7 in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [ALS](/diseases/amyotrophic-lateral-sclerosis) is mechanistic rather than monogenic: small shifts in background potassium conductance can alter firing stability, calcium loading, and metabolic demand, all of which interact with [mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction), [excitotoxicity](/mechanisms/excitotoxicity), and [neuroinflammation](/mechanisms/neuroinflammation).[@enyedi2010][@styr2018][@martin2010]
KCNK7 belongs to the K2P channel family, which is structurally defined by four transmembrane helices and two pore-forming domains per subunit; functional channels are assembled as dimers.[@goldstein2005][@enyedi2010] This architecture supports constitutive or weakly gated K+ flux, creating the "leak" conductance that stabilizes membrane voltage around subthreshold ranges.[@enyedi2010][@feliciangeli2015]
K2P channels are not simple passive pores. Many integrate pH, stretch, temperature, lipids, and neuromodulators to tune excitability over long timescales.[@enyedi2010][@feliciangeli2015] Even when KCNK7-specific electrophysiology is sparse, family-level principles justify disease relevance: reductions in leak conductance increase membrane resistance and can amplify depolarizing inputs, while excess conductance can suppress adaptive firing and network responsiveness.[@enyedi2010][@styr2018]
Transcript resources and curated channel atlases indicate KCNK7 expression in nervous-system tissues with additional peripheral expression.[@goldstein2005][@fagerberg2014] In systems terms, background K+ channels most strongly influence:
These functions are especially relevant in regions already vulnerable to proteostasis and mitochondrial stress, including cortical and basal-ganglia circuits implicated across AD/PD spectrum disorders.[@styr2018][@martin2010]
When background K+ buffering is reduced, neurons spend more time near depolarized states, increasing calcium entry via voltage-dependent pathways and potentiating excitotoxic cascades.[@styr2018][@parsons2014] This creates feed-forward interactions with synaptic glutamatergic stress and oxidative injury, established mechanisms across major neurodegenerative diseases.[@styr2018][@martin2010][@parsons2014]
Hyperexcitability raises ATP demand and [ROS](/entities/reactive-oxygen-species) production. In neurons with pre-existing mitochondrial compromise, even modest ion-channel dysregulation can lower resilience and accelerate degeneration.[@martin2010][@mattson2008] KCNK7 should therefore be interpreted as a potential modifier of energy-stress thresholds rather than a standalone causal lesion.
Cytokine-rich microenvironments alter ion-channel expression and membrane properties, while abnormal excitability can further promote inflammatory signaling and synaptic dysfunction.[@martin2010][@heneka2014] This bidirectional loop makes leak-channel biology relevant to disease progression models, especially where glial activation is persistent.
At present, KCNK7 is not among the strongest repeatedly replicated Mendelian drivers of AD/PD/ALS. However, two clinically meaningful categories remain:
This is consistent with broader ion-channel literature, where distributed small effects can still materially shape circuit stability in chronic neurodegeneration.
Direct KCNK7-selective drugs are not yet in routine clinical use. Near-term translational strategies are therefore pathway-level: